magnesium sulfate has been researched along with Dyspnea in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Aye, SZ; Naing, C; Ni, H | 1 |
Baniasadi, S; Farzanegan, B; Jafarzadeh, M; Kashefizadeh, A; Meybodi, ZA; Mousavinasab, SR; Pourdowlat, G | 1 |
Dunder, T; Kallio, M; Pokka, T; Pruikkonen, H; Renko, M; Tapiainen, T; Uhari, M | 1 |
Benger, J; Bradburn, M; Coats, T; Cohen, J; Goodacre, S; Gray, A; Stevens, J | 1 |
Carwana, M; Cook, VE; Kapur, A; Li, R; Martin, G; Sauve, L; Tang, P; Tilley, P; Yang, CL | 1 |
Gaur, S; Kumar, R; Singh, AK | 1 |
Goodacre, S; Jones, LA | 1 |
1 review(s) available for magnesium sulfate and Dyspnea
Article | Year |
---|---|
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
Topics: Disease Progression; Dyspnea; Humans; Ipratropium; Magnesium; Magnesium Sulfate; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2022 |
4 trial(s) available for magnesium sulfate and Dyspnea
Article | Year |
---|---|
Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Topics: Administration, Inhalation; Blood Gas Analysis; Bronchodilator Agents; Calcium Channel Blockers; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Humans; Hypoxia; Iran; Magnesium Sulfate; Nebulizers and Vaporizers; Randomized Controlled Trials as Topic; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vasodilator Agents; Ventilation-Perfusion Ratio | 2021 |
Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial.
Topics: Acute Disease; Administration, Intravenous; Albuterol; Asthma; Bronchodilator Agents; Child, Preschool; Double-Blind Method; Dyspnea; Female; Finland; Humans; Infant; Logistic Models; Magnesium Sulfate; Male; Respiratory Sounds; Severity of Illness Index; Treatment Outcome | 2018 |
The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Asthma; Bronchodilator Agents; Double-Blind Method; Dyspnea; Emergency Service, Hospital; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Nebulizers and Vaporizers; Outcome and Process Assessment, Health Care; Patient Admission; Patient Satisfaction; Quality-Adjusted Life Years; Severity of Illness Index; Sex Distribution; United Kingdom; Visual Analog Scale; Young Adult | 2014 |
A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Albuterol; Drug Therapy, Combination; Dyspnea; Female; Forced Expiratory Volume; Humans; Injections, Intravenous; Ipratropium; Magnesium Sulfate; Male; Middle Aged; Peak Expiratory Flow Rate; Status Asthmaticus; Treatment Outcome | 2008 |
2 other study(ies) available for magnesium sulfate and Dyspnea
Article | Year |
---|---|
Respiratory Presentation of Pediatric Patients in the 2014 Enterovirus D68 Outbreak.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Infective Agents; British Columbia; Calcium Channel Blockers; Child; Child, Preschool; Continuous Positive Airway Pressure; Cough; Disease Outbreaks; Dyspnea; Enterovirus D, Human; Enterovirus Infections; Female; Humans; Hypoxia; Infant; Intensive Care Units, Pediatric; Lung; Magnesium Sulfate; Male; Oxygen Inhalation Therapy; Radiography, Thoracic; Respiratory Sounds; Respiratory Tract Infections; Retrospective Studies; Seasons; Tachycardia; Tachypnea | 2016 |
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments.
Topics: Acute Disease; Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Dyspnea; Emergency Medicine; Emergency Service, Hospital; Health Surveys; Humans; Infusions, Intravenous; Magnesium Sulfate; Professional Practice | 2009 |